*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Characterization and Formulation of Transdermal Drug Delivery System of Piroxicam

Author: ROHINI BHATTACHARYA, AFRASIM MOIN, NANHI NANDINI, MEENAKSHI S, SIDDARAMAIAH, SATHISH BABU P, NITHIN K.S, D V GOWDA
Abstract: The present study aimed to characterize water-insoluble non- steroidal anti-inflammatory drug [NSAID], Piroxicam [PXC], and formulate a transdermal patch. Characterization of the drug was done by Differential Scanning Calorimetry [DSC] and Fourier-Transform Infrared Spectroscopy [FTIR]. Powder X-ray Diffraction [PXRD] was carried out to confirm the identity of crystals. The solubility of Piroxicam was increased by preparing co-crystals of Piroxicam with succinic acid. The co-crystals were prepared by using Piroxicam and Succinic acid both by fast and slow evaporation methods of crystallization. Acetone of HPLC grade was used as a solvent for crystal formation. Rod and hexagonal-shaped crystals were observed under a microscope and later the identity was confirmed by Powder X-ray Diffraction. The supersaturated mixture was prepared for transdermal formulation and permeation was enhanced by co-former. Fourier-Transform Infrared Spectroscopy and Differential Scanning Calorimetry confirmed that there were no interactions between the drug and conformer. Due to the formation of co-crystals, water solubility was enhanced which was confirmed by in-vitro dissolution. An in-vitro skin study was carried out for the prepared transdermal formulation. To conclude, the co-crystal based formulation of Piroxicam and succinic acid provides better solubility than the individual drug and offers promising results for drug permeation through the transdermal delivery system.
Keyword: Co-crystals, Supersaturation, Transdermal drug delivery, Piroxicam, Crystallization, Succinic acid
DOI: https://doi.org/10.31838/ijpr/2021.13.01.404
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free